TOGAS brings together researchers, clinicians, and advocates from 14 European countries to develop gastric cancer prevention programmes that work for diverse populations across the EU.
"The TOGAS study results will inform how Europe develops gastric cancer prevention programs," says Jan Bornschein, PS2 lead researcher and representing our consortium member Otto-von Guericke University Magdeburg.
United by our commitment to seeing the person before the patient, we're building a future where gastric cancer prevention is accessible, effective, and tailored to individuals across Europe.